Zeto Inc., a provider of a wearable EEG monitoring system, raised $31 million in Series B Funding.
The funding round was led by MindWorks Global, a Michigan-based investment entity funded by visionary entrepreneur-investors with a track record of building multi-billion-dollar enterprises.
Zeto Inc., founded in 2014 and headquartered in Santa Clara, California, is a medical technology company specializing in advanced electroencephalography (EEG) device systems. Their flagship product, the Zeto EEG headset, is an FDA-cleared, wireless, dry electrode device designed to remotely monitor the brain’s electrical activity without the need for gels or wires.
The Zeto technology transforms the traditional EEG experience, cutting setup times dramatically—from the usual 20-30 minutes to just about five. This shift not only simplifies the process for clinicians but also makes the experience far more comfortable for patients, paving the way for faster diagnostics and smoother operations in medical settings.
The EEG system includes a cloud-based platform that offers real-time data streaming, video integration, and tools for analysis, facilitating remote monitoring and interpretation by neurologists. This comprehensive solution is utilized in various settings, including hospitals, clinics, and research institutions, to diagnose and treat neurological conditions such as epilepsy, sleep disorders, autism, stroke, and concussion.
In addition to their hardware solutions, Zeto has partnered with companies like Next Gen Neuro to provide remote EEG monitoring services, expanding access to EEG diagnostics across diverse healthcare facilities in the U.S.
“Zeto is grateful for the steadfast support and continued investments from its prior investors over the years. This new funding will enable Zeto to expand its commercial and operational teams, drive further growth, and strengthen ongoing research and development efforts,” the company stated in the press statement.
“Zeto has reached a pivotal milestone, earning a reputation for game-changing innovation and experiencing rapid adoption of our solutions by leading healthcare institutions across the U.S.,” said Aswin Gunasekar, Zeto’s Founder and CEO.”
“Our management team has long aspired to collaborate with accomplished entrepreneur-investors who have successfully scaled companies to drive meaningful societal impact and significant revenue. We are excited to welcome MindWorks Global partners to our board of directors who bring not only capital but also invaluable expertise, extensive experience, and a powerful network. Our dedicated team is eager to embark on this exciting next chapter in our company’s journey,” added Aswin Gunasekar.